Skip to Content
MilliporeSigma
  • Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.

Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.

Thrombosis research (2015-09-05)
Jeffrey A Kline, Nury M Steuerwald, John A Watts, Mark Courtney, Herbert L Bonkovsky
ABSTRACT

Pulmonary embolism (PE) can cause intracardiac hemolysis and increased plasma hemoglobin and arginase-1, which can worsen pulmonary vasoconstriction. We test the hypothesis that patients with PE that causes tricuspid regurgitation (TR), indicative of higher pulmonary arterial pressures, have decreased leukocyte expression of hmox-1 compared with patients with PE and no TR and patients without PE. Prospective, noninterventional study. Normotensive patients with suspected PE (n=87) who underwent CT pulmonary angiography and transthoracic Doppler-echocardiography. Significant TR was defined as a jet velocity >2.7m/s. Leukocyte expression of hmox-1, haptoglobin, haptoglobin related gene, the haptoglobin receptor, CD163 and cox-2 genes were assessed by quantitative rtPCR, and the hmox-1 promoter was examined for the -413 A→T SNP and GT repeat polymorphisms. Of the 44 (50%) with PE+, 22 had TR+, and their mean pulmonary vascular occlusion (39±32%) did not differ significantly from patients who were TR- (28±26%, P=0.15). Patients with PE+ and TR+ had significantly lower expression of hmox-1 and haptoglobin genes than patients without PE+ and no TR. Expression of hmox-1 varied inversely with TR velocity (r(2)=0.45, P<0.001) for PE+ (n=22) but not patients without PE. Hmox-1 expression did not vary significantly with genotype. Cox-2 did not differ between groups and had no correlation with TR. Severity of TR varied inversely with hmox-1 expression, suggesting that hmox-1 expression affects pulmonary vascular reactivity after PE.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Titanium tetrachloride, packaged for use in deposition systems
Sigma-Aldrich
Formamide, JIS special grade, ≥98.5%
Sigma-Aldrich
Formamide, SAJ first grade, ≥98.5%
Sigma-Aldrich
5-Carboxyfluorescein, BioReagent, suitable for fluorescence, ≥95% (HPLC)
Sigma-Aldrich
Formamide, BioUltra, for molecular biology, ≥99.5% (T)
Sigma-Aldrich
Formamide, ACS reagent, ≥99.5%
Sigma-Aldrich
Trisodium citrate dihydrate, meets USP testing specifications
Sigma-Aldrich
Formamide, BioReagent, ≥99.5% (GC), for molecular biology
Sigma-Aldrich
Formamide, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
Titanium(IV) chloride solution, 1.0 M in methylene chloride
Sigma-Aldrich
Formamide, spectrophotometric grade, ≥99%
Sigma-Aldrich
Titanium(IV) chloride solution, 0.09 M in 20% HCl
Sigma-Aldrich
Sodium citrate tribasic dihydrate, JIS special grade, ≥99.0%
Sigma-Aldrich
Sodium citrate dihydrate, ≥99%, FG
Sigma-Aldrich
Sodium citrate tribasic dihydrate, for molecular biology, ≥99%
Sigma-Aldrich
Sodium citrate tribasic dihydrate, ≥98%
Sigma-Aldrich
Sodium citrate tribasic dihydrate, BioUltra, for molecular biology
Supelco
Formamide solution, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
Sigma-Aldrich
Sodium citrate tribasic dihydrate, ACS reagent, ≥99.0%
Sigma-Aldrich
Formamide solution, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 10 mm × 8 in.
Sigma-Aldrich
Titanium(IV) chloride, ≥99.995% trace metals basis
Sigma-Aldrich
Titanium(IV) chloride, ReagentPlus®, 99.9% trace metals basis